These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 736975)

  • 21. Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine.
    Glowinski J; Axelrod J; Iversen LL
    J Pharmacol Exp Ther; 1966 Jul; 153(1):30-41. PubMed ID: 4380692
    [No Abstract]   [Full Text] [Related]  

  • 22. Modification by desipramine (DMI) of the availability of norepinephrine released by reserpine in the hypothalamus of the rat in vivo.
    Sulser F; Owens ML; Strada SJ; Dingell JV
    J Pharmacol Exp Ther; 1969 Aug; 168(2):272-82. PubMed ID: 5803311
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus.
    Ferris RM; Tang FL
    J Pharmacol Exp Ther; 1979 Sep; 210(3):422-8. PubMed ID: 39160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons.
    Nybäck HV; Walters JR; Aghajanian GK; Roth RH
    Eur J Pharmacol; 1975; 32(02):302-12. PubMed ID: 1149813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychoactive drugs and brain neurochemical transmitters.
    Valzelli L
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:221+. PubMed ID: 4342945
    [No Abstract]   [Full Text] [Related]  

  • 27. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
    Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
    Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral circulatory and metabolic effects of piribedil.
    McCulloch J; Edvinsson L
    Eur J Pharmacol; 1980 Sep; 66(4):327-37. PubMed ID: 7418723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological and biochemical responses of noradrenergic neurons to a non-amphetamine CNS stimulant.
    German DC; Sanghera MK; Kiser RS; McMillen BA; Shore PA
    Brain Res; 1979 Apr; 166(2):331-9. PubMed ID: 427592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor dynamics: effect of repeated administration of desmethylimipramine on the noradrenergic systems in rat brain.
    Bürki HR; Rüdeberg C; Taimisto EL
    Postgrad Med J; 1981; 57 Suppl 1():71-6. PubMed ID: 6272253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine.
    Strada SJ; Sanders-Bush E; Sulser F
    Biochem Pharmacol; 1970 Sep; 19(9):2621-9. PubMed ID: 5478286
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4.
    Calderini G; Morselli PL; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs.
    Aghajanian GK; Bloom FE
    J Pharmacol Exp Ther; 1967 Jun; 156(3):407-16. PubMed ID: 6027453
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of piribedil (ET-495) on plasma norepinephrine: relationship to antidepressant response.
    Reus VI; Lake CR; Post RM
    Commun Psychopharmacol; 1980; 4(3):207-13. PubMed ID: 7226752
    [No Abstract]   [Full Text] [Related]  

  • 35. On the interaction between caffeine and barbiturates with respect to locomotor activity and brain catecholamines.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):172-80. PubMed ID: 1173516
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
    Lacroix D; Blier P; Curet O; de Montigny C
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices.
    Ng KY; Chase TN; Kopin IJ
    Nature; 1970 Oct; 228(5270):468-9. PubMed ID: 5482502
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.